Drug Therapy, Combination

"Drug Therapy, Combination" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Therapy with two or more separate preparations given for a combined effect.

Descriptor ID	D004359
MeSH Number(s)	E02.319.310
Concept/Terms	Drug Therapy, Combination Drug Therapy, Combination Combination Chemotherapy Drug Polytherapy Drug Polytherapies Polytherapies, Drug Polytherapy, Drug Therapy, Combination Drug Chemotherapy, Combination Chemotherapies, Combination Combination Chemotherapies Combination Drug Therapy Combination Drug Therapies Drug Therapies, Combination Therapies, Combination Drug Polychemotherapy Polychemotherapy Polychemotherapies

Below are MeSH descriptors whose meaning is more general than "Drug Therapy, Combination".

Analytical, Diagnostic and Therapeutic Techniques and Equipment [E]
Therapeutics [E02]
Drug Therapy [E02.319]
Drug Therapy, Combination [E02.319.310]

Below are MeSH descriptors whose meaning is more specific than "Drug Therapy, Combination".

Drug Therapy, Combination
Antineoplastic Combined Chemotherapy Protocols
Antiretroviral Therapy, Highly Active

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Drug Therapy, Combination" by people in this website by year, and whether "Drug Therapy, Combination" was a major or minor topic of these publications.

Bar chart showing 195 publications over 28 distinct years, with a maximum of 14 publications in 2011 and 2019

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1996	0	1	1
1997	0	1	1
1998	0	1	1
1999	1	1	2
2000	0	2	2
2002	0	7	7
2003	0	7	7
2004	0	11	11
2005	0	8	8
2006	0	13	13
2007	1	12	13
2008	0	12	12
2009	0	7	7
2010	0	7	7
2011	0	14	14
2012	0	8	8
2013	0	6	6
2014	0	5	5
2015	0	12	12
2016	0	10	10
2017	0	10	10
2018	0	8	8
2019	1	13	14
2020	0	5	5
2021	0	6	6
2022	0	2	2
2023	0	1	1
2024	0	2	2

Below are the most recent publications written about "Drug Therapy, Combination" by people in Profiles.

Maykin MM, Mercer E, Saiki KM, Kaneshiro B, Miller CB, Tsai PS. Furosemide to lower antenatal severe hypertension: a randomized placebo-controlled trial. Am J Obstet Gynecol MFM. 2024 Apr; 6(4):101348.

View in: PubMed
Roche-Lima A, Rosado-Qui?ones AM, Feliu-Maldonado RA, Figueroa-Gispert MDM, D?az-Rivera J, D?az-Gonz?lez RG, Carrasquillo-Carrion K, Nieves BG, Col?n-Lorenzo EE, Serrano AE. Antimalarial Drug Combination Predictions Using the Machine Learning Synergy Predictor (MLSyPred?) tool. Acta Parasitol. 2024 Mar; 69(1):415-425.

View in: PubMed
Amaral JK, Bingham CO, Taylor PC, Vil? LM, Weinblatt ME, Schoen RT. Therapy for Chikungunya Arthritis: A Study of 133 Brazilian Patients. Am J Trop Med Hyg. 2023 09 06; 109(3):542-547.

View in: PubMed
Deng Y, Polley EC, Wallach JD, Dhruva SS, Herrin J, Quinto K, Gandotra C, Crown W, Noseworthy P, Yao X, Lyon TD, Shah ND, Ross JS, McCoy RG. Emulating the GRADE trial using real world data: retrospective comparative effectiveness study. BMJ. 2022 10 03; 379:e070717.

View in: PubMed
Park J, Jung JH, Choi EK, Lee SW, Kwon S, Lee SR, Kang J, Han KD, Park KW, Oh S, Lip GYH. Comparison of early clinical outcomes between dual antiplatelet therapy and triple antithrombotic therapy in patients with atrial fibrillation undergoing percutaneous coronary intervention. PLoS One. 2022; 17(2):e0264538.

View in: PubMed
Shankar-Hari M, Vale CL, Godolphin PJ, Fisher D, Higgins JPT, Spiga F, Savovic J, Tierney J, Baron G, Benbenishty JS, Berry LR, Broman N, Cavalcanti AB, Colman R, De Buyser SL, Derde LPG, Domingo P, Omar SF, Fernandez-Cruz A, Feuth T, Garcia F, Garcia-Vicuna R, Gonzalez-Alvaro I, Gordon AC, Haynes R, Hermine O, Horby PW, Horick NK, Kumar K, Lambrecht BN, Landray MJ, Leal L, Lederer DJ, Lorenzi E, Mariette X, Merchante N, Misnan NA, Mohan SV, Nivens MC, Oksi J, Perez-Molina JA, Pizov R, Porcher R, Postma S, Rajasuriar R, Ramanan AV, Ravaud P, Reid PD, Rutgers A, Sancho-Lopez A, Seto TB, Sivapalasingam S, Soin AS, Staplin N, Stone JH, Strohbehn GW, Sunden-Cullberg J, Torre-Cisneros J, Tsai LW, van Hoogstraten H, van Meerten T, Veiga VC, Westerweel PE, Murthy S, Diaz JV, Marshall JC, Sterne JAC. Association Between Administration of IL-6 Antagonists and Mortality Among Patients Hospitalized for COVID-19: A Meta-analysis. JAMA. 2021 08 10; 326(6):499-518.

View in: PubMed
Rom?n M, Garc?a L, Morales M, Crespo MJ. The combination of dantrolene and nimodipine effectively reduces 5-HT-induced vasospasms in diabetic rats. Sci Rep. 2021 05 10; 11(1):9852.

View in: PubMed
Tewary P, Brooks AD, Xu YM, Wijeratne EMK, Babyak AL, Back TC, Chari R, Evans CN, Henrich CJ, Meyer TJ, Edmondson EF, de Aquino MTP, Kanagasabai T, Shanker A, Gunatilaka AAL, Sayers TJ. Small-Molecule Natural Product Physachenolide C Potentiates Immunotherapy Efficacy by Targeting BET Proteins. Cancer Res. 2021 06 15; 81(12):3374-3386.

View in: PubMed
Torrico F, Gasc?n J, Barreira F, Blum B, Almeida IC, Alonso-Vega C, Barboza T, Bilbe G, Correia E, Garcia W, Ortiz L, Parrado R, Ramirez JC, Ribeiro I, Strub-Wourgaft N, Vaillant M, Sosa-Estani S. New regimens of benznidazole monotherapy and in combination with fosravuconazole for treatment of Chagas disease (BENDITA): a phase 2, double-blind, randomised trial. Lancet Infect Dis. 2021 08; 21(8):1129-1140.

View in: PubMed
Clements DM, Crumley B, Chew GM, Davis E, Bruhn R, Murphy EL, Ndhlovu LC, Jain P. Phenotypic and Functional Analyses Guiding Combination Immune Checkpoint Immunotherapeutic Strategies in HTLV-1 Infection. Front Immunol. 2021; 12:608890.

View in: PubMed

People

Explore

Similar Concepts

Top Journals